This month, several prominent technology companies revealed new artificial intelligence (AI) and virtual reality (VR) advancements designed to strengthen healthcare delivery and operational efficiency within health systems. Among the companies releasing updates are Oracle, Medtronic, Atropos Health, Elation Health, LeanTaaS, and Palantir.
These innovations reflect an ongoing trend of digital transformation in healthcare, where AI and VR technologies are increasingly being integrated into clinical workflows, administrative processes, and patient engagement tools.
Oracle has expanded its health IT capabilities, introducing AI-driven tools to enhance data insights and support clinical decision-making within its electronic health record (EHR) systems. Medtronic, a leader in medical technology, has introduced AI-powered algorithms to assist with surgical planning and improve outcomes through precision guidance.
Startups like Atropos Health and Elation Health are focusing on AI based solutions for personalized patient care and streamlined provider management platforms, respectively. These tools aim to support clinicians with evidence-based recommendations at the point of care.
LeanTaaS has upgraded its AI-powered scheduling platforms, which help hospitals maximize the use of operating rooms and infusion centers by predicting demand and suggesting optimized scheduling. Meanwhile, Palantir Technologies is leveraging its data analytics platform to provide health systems with the capability to synthesize complex datasets in real-time, supporting population health management and strategic planning.
These advancements are designed to address various challenges in modern healthcare delivery, including rising operational costs, clinician burnout, and the need for more precise and personalized care. As health systems look to do more with fewer resources post-pandemic, the adoption of smart technologies is becoming a critical part of the healthcare infrastructure.
The growing presence of next-generation technology in healthcare signals a broader commitment across the industry to harness innovation for systemic improvements and enhanced patient outcomes.
Source: https:// – Courtesy of the original publisher.
